维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Chambers CE"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Prevention of contrast induced nephropathy: recommendations for zhe high risk patient undergoing cardiovas culor procedures 显示文摘	Schweiger M J Chambers CE Davidson CJ	2007	Catheter Cardiovasc Interv2007，69，3：	1
	2	The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘	International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M	2010	Science2010，330，6010：	1
	3	Radiation safety program for the cardiac catheterization laboratory 显示文摘	Chambers CE Fetterly KA Holzer R	2011	Catheter Cardiovasc Interv2011，77，4：	1
	4	Prevention of contrast induced nephropathy:recommendations for the high risk patient undergoing cardiovascular procedures显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter Cardiovasc Interv2007，69，1：	1
	5	Prevention of contrast induced nephropathy j recom-mendations for the high risk patient undergoing car-diovascular procedures显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter Cardiovasc In-terv2007，69，1：	1
	6	Cardiac surgery during pregnancy 显示文摘	Chambers CE Clark SL	1994	Clin Obstet Gynecol1994，37，2：	1
	7	Ability of dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events显示文摘	O'Meara J Chambers CE	1990	Am J Cardiol1990，65，3：	1
	8	Prevention of contrast induced nephropathy : recommendations for zhe high risk- patient undergoing cardiovascul or procedures显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter Card- iovasc Interv2007，69，1：	1
	9	Pyrazinolguanidine:antihypertensive,hypocholesterolemic, and Rennin effects 显示文摘	Chambers CE Vesell ES Hem C	1992	J Clin Pharmacol1992，32，：	1
	10	Pre vention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedurcs显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter Cardiovasc Inter2007，69，1：	1
	11	Effects of pyrazinol- guanidine on the glucose-fatty acid cycle innormal subjects and patients with non-insulin dependent diabetes mellitus显示文摘	Vesell ES Chambers CE Passananti T	1993	J Clin Pharmacol1993，33，：	1
	12	Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures 显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter Cardiovasc Interv2007，69，1：	1
	13	Prevention of contrast induced nephropa- thy:Recommendations for the high risk patient undergoing cardiovas- cular procedures 显示文摘	Schweiger M J Chambers CE	2007	Catheter Cardiovasc lnterven2007，69，1：	1
	14	Prevention of contrast induced nephropathy:recommendations for the high risk patient undergoing cardiovascular procedures显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter Cardiovasc Interv2007，69，1：	1
	15	Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures显示文摘	Schweiger M J Chambers CE Davidson C J	2007	Catheter Cardiovasc Interv2007，69，1：	1
	16	Prevention of con-trast induced nephropathy:recommendations for the high risk pa-tient undergoing cardiovascular procedures 显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter CardiovascInterv2007，69，1：	1
	17	Prevention of contrast induced nephropathy:recommendations for the high risk patient undergoing cardiovascular procedures显示文摘	Schweiger MJ Chambers CE Davidson CJ	2007	Catheter Cardiovasc Interv2007，69，1：	1
	18	Quantitation of HeLa cell monolayer invasion by Shigella and Salmonella species显示文摘	Niesel DW Chambers CE Stockman SL	1985	J Clin Microbiol1985，22，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费